Delhi High Court restrained Glenmark Pharmaceuticals from manufacturing and selling its anti-diabetes drugs Zita and Zita-Met, saying it has infringed the patent of the American company.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
